Evaluation of the Expression EGFR, HER2/NEU and the End Effector ERK of the RAS/RAF/MAP Kinase Pathway in Prostatic Adenocarcinoma for a Possible Role as New Target Therapy.

Autor: Shalaby, Asem, Mahmoud, Heba A., Sayed, Shaymaa G., Al Hashmi, Khalid, Al Sinawi, Shadia, Al Badi, Suaad, Al Rashdi, Afrah, Al Husaini, Samya, Al Badi, Hajer, Saad El-Din, Somaia Ahmed
Zdroj: Asian Pacific Journal of Cancer Prevention; Jun2024, Vol. 25 Issue 6, p2193-2201, 9p
Databáze: Complementary Index